slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,578
Current window 101,281-101,310
Pages 3,953
Rows per page 30
Component
101,281-101,310 of 118,578
17
The slide uses a simple additive equation to define the product's core benefit, followed by a chevron-based timeline for life cycle management.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations 1 hit
21
The chart shows dose-response curves where LNC formulations consistently outperform Taxol.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations 1 hit
24
Includes longitudinal line charts and bar charts for Day 7 endpoints across 5 treatment groups.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations 1 hit
27
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations 1 hit
01
ModivCare | Investor Presentation Deck | 45 slidesModivCare | Investor Presentation Deck | 45 slides · ModivCare
Pitch deck Investor relations 1 hit
04
The slide uses a three-stage process flow (Legacy, Transformation, 2024 & Beyond) to illustrate strategic growth.ModivCare | Investor Presentation Deck | 45 slides · ModivCare
Pitch deck Investor relations 1 hit
32
The chart is a stacked bar chart showing the composition of Medicaid outcomes by state.ModivCare | Investor Presentation Deck | 45 slides · ModivCare
Pitch deck Investor relations 1 hit
42
The table provides a detailed breakdown of operating expenses, income, and adjustments for NEMT, PCS, RPM, and Corporate segments.ModivCare | Investor Presentation Deck | 45 slides · ModivCare
Pitch deck Investor relations 1 hit
43
Includes segment-level breakdown for NEMT, Personal Care, RPM, and Corporate/Other.ModivCare | Investor Presentation Deck | 45 slides · ModivCare
Pitch deck Investor relations 1 hit
44
Standard financial disclosure slide for non-GAAP metrics.ModivCare | Investor Presentation Deck | 45 slides · ModivCare
Pitch deck Investor relations 1 hit
05
The diagram uses a central 'Moelis' hub connecting three overlapping circles representing core business pillars.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a grid layout to categorize client work by service line, with a sidebar for industry recognition.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
The slide uses a three-row layout to categorize ESG efforts into Environmental, Social, and Governance pillars.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · Market SizeLoop · Golden Circle1 hit
16
The slide uses a three-column layout to categorize HR initiatives.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Loop · Golden Circle1 hit
17
The chart includes a break in the x-axis between 2014 and 2019.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Loop · Golden Circle1 hit
01
Morgan Stanley | Investor Presentation Deck | 23 slidesMorgan Stanley | Investor Presentation Deck | 23 slides · Morgan Stanley
Conference presentation Investor relations 1 hit
20
This slide provides technical definitions for terms like Core Client Relationships, NNA, and Fee-Based Flows used in the presentation.Morgan Stanley | Investor Presentation Deck | 23 slides · Morgan Stanley
Conference presentation Investor relations 1 hit
23
Morgan Stanley | Investor Presentation Deck | 23 slidesMorgan Stanley | Investor Presentation Deck | 23 slides · Morgan Stanley
Conference presentation Investor relations 1 hit
01
Nuvalent | Investor Presentation Deck | 42 slidesNuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
04
The slide uses a 'The Nuvalent Approach' framing to outline their core methodology.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
05
The slide uses a timeline-based structure to demonstrate operational momentum.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
06
The slide uses a timeline to show the progression from global strategy execution to product approval, complemented by a list of 2024 milestones.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
10
The slide uses a 'Case Study' framework to validate the strategy by comparing it to the established success of Osimertinib in EGFR+ NSCLC.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · SolutionLoop · Pattern Hunter1 hit
12
The slide uses a sidebar 'AT A GLANCE' to summarize key product attributes.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
17
Includes detailed patient enrollment table by dose cohort and trial objectives.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
21
Swimmer plot showing patient-level treatment duration with ongoing status and response markers.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
24
The chart shows pharmacokinetic data across five dose cohorts, demonstrating that the 150mg dose consistently stays above the predicted CNS efficacy thresholds.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
31
The slide presents a summary of a clinical trial, including patient eligibility criteria and a breakdown of patient cohorts by dose level.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
36
RP2D = Recommended Phase 2 Dose; QD = once daily; MTD = Maximum Tolerated Dose.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
38
The slide outlines a multi-cohort study design with specific patient populations (TKI-naive vs pre-treated) and objectives.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit